Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,517 | 134 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $692.39 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $604.61 | 24 | $0 (2024) |
| GlaxoSmithKline, LLC. | $589.04 | 22 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $282.61 | 8 | $0 (2024) |
| Lilly USA, LLC | $205.78 | 10 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $200.81 | 7 | $0 (2022) |
| ABBVIE INC. | $166.60 | 5 | $0 (2023) |
| Amarin Pharma Inc. | $147.28 | 10 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $141.96 | 2 | $0 (2021) |
| Merck Sharp & Dohme LLC | $104.20 | 5 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $735.41 | 29 | Novo Nordisk Inc ($226.98) |
| 2023 | $577.90 | 20 | AstraZeneca Pharmaceuticals LP ($180.03) |
| 2022 | $488.08 | 23 | AstraZeneca Pharmaceuticals LP ($122.85) |
| 2021 | $1,715 | 62 | Novo Nordisk Inc ($360.11) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $120.88 | General |
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $21.32 | General |
| 09/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $23.15 | General |
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $37.79 | General |
| Category: Neuroscience | ||||||
| 07/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Inflammation | ||||||
| 06/28/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: RESPIRATORY | ||||||
| 06/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: VACCINES | ||||||
| 04/23/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/09/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Diabetes | ||||||
| 03/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $4.32 | General |
| Category: Obesity | ||||||
| 03/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: DIABETES | ||||||
| 02/27/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Diabetes | ||||||
| 02/15/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Diabetes | ||||||
| 02/13/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Obesity | ||||||
| 02/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Diabetes | ||||||
| 01/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
About Nilo Reyes
Nilo Reyes is a Family healthcare provider based in Bellflower, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/26/2020. The National Provider Identifier (NPI) number assigned to this provider is 1770117020.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nilo Reyes has received a total of $3,517 in payments from pharmaceutical and medical device companies, with $735.41 received in 2024. These payments were reported across 134 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,517).
Practice Information
- Specialty Family
- Location Bellflower, CA
- Active Since 02/26/2020
- Last Updated 02/26/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1770117020
Products in Payments
- TRELEGY ELLIPTA (Drug) $550.29
- FARXIGA (Drug) $317.11
- JARDIANCE (Drug) $278.89
- RYBELSUS (Drug) $270.77
- BREZTRI (Drug) $200.99
- Kerendia (Drug) $200.81
- Ozempic (Drug) $185.43
- Vascepa (Drug) $147.28
- ProAir Digihaler (Drug) $122.31
- QULIPTA (Drug) $90.51
- MOUNJARO (Drug) $87.51
- UBRELVY (Drug) $76.09
- Rybelsus (Drug) $68.40
- Otezla (Drug) $64.13
- GARDASIL 9 (Biological) $63.75
- GVOKE HYPOPEN (Drug) $61.08
- AIRSUPRA (Drug) $46.20
- PREVNAR 20 (Biological) $42.00
- EMGALITY (Drug) $41.67
- JANUVIA (Drug) $40.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Bellflower
Denise Fisher, Fnp-C, FNP-C
Family — Payments: $1,580
Mrs. Appolonia Olumba
Family — Payments: $1,342
Gisselle Lara, Fnp, FNP
Family — Payments: $811.02
Leo Monillas, Msn-Fnp, MSN-FNP
Family — Payments: $580.47
Irma Galang, Fnp, FNP
Family — Payments: $531.34
Maria Cecilia Figueroa, Np-C, NP-C
Family — Payments: $238.53